tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Syntara Limited Resumes Trading on ASX

Story Highlights
Syntara Limited Resumes Trading on ASX

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.

Syntara Limited, a company listed on the Australian Securities Exchange (ASX), has announced the reinstatement of trading in its securities. This follows the submission of its quarterly activity and cash flow reports for the quarter ending June 30, 2025. The lifting of the trading suspension is expected to positively impact Syntara Limited by restoring investor confidence and enhancing its market presence.

The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.

More about Pharmaxis Ltd

Average Trading Volume: 9,860,498

Technical Sentiment Signal: Hold

Current Market Cap: A$97.65M

For detailed information about SNT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1